Steven Prestrelski, Chief Scientific Officer at XERIS PHARMACEUTICALS INC (XERS), sold 10,000 shares at $9.56 ($96K) on 2019-04-11, disclosed to the SEC on 2019-04-12.
Open-market sale of $96k XERS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| XERS | SELL | 2021-01-15 | $60K | — | Filing → |
| XERS | SELL | 2021-01-12 | $57K | — | Filing → |
| XERS | SELL | 2020-01-14 | $55K | — | Filing → |